Beats Medical's mission is to deliver digital assessments and therapeutics that transform how central nervous system conditions & rare diseases are managed and understood, to unlock the therapies of the future. Using our patented platform technology, Colbolt, we deploy applications that provide automated, objective assessments to enhance clinical research, and individualized, progressive therapies to promote independent symptom management. Beats Medical’s cutting-edge approach to digitizing clinically proven assessments and therapies is device agnostic, requiring only a smartphone, with no additional hardware or sensors needed. With our embedded digital biomarkers approach, we facilitate a greater exploration of data from the initial phases of clinical trials, through to long-term real world evidence generation. This unique digital biomarker focus is what fuels Beats Medical’s vision to unlock the healthcare breakthroughs of the future, today.